FI973521A7 - Menetelmät munasarjasyövän inhiboimiseksi - Google Patents

Menetelmät munasarjasyövän inhiboimiseksi Download PDF

Info

Publication number
FI973521A7
FI973521A7 FI973521A FI973521A FI973521A7 FI 973521 A7 FI973521 A7 FI 973521A7 FI 973521 A FI973521 A FI 973521A FI 973521 A FI973521 A FI 973521A FI 973521 A7 FI973521 A7 FI 973521A7
Authority
FI
Finland
Prior art keywords
methods
ovarian cancer
inhibiting ovarian
inhibiting
cancer
Prior art date
Application number
FI973521A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973521L (fi
FI973521A0 (fi
Inventor
Robin S Lee Fuchs-Young
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI973521L publication Critical patent/FI973521L/fi
Publication of FI973521A0 publication Critical patent/FI973521A0/fi
Publication of FI973521A7 publication Critical patent/FI973521A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
FI973521A 1995-02-28 1996-02-27 Menetelmät munasarjasyövän inhiboimiseksi FI973521A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39595195A 1995-02-28 1995-02-28
PCT/US1996/002621 WO1996026727A1 (en) 1995-02-28 1996-02-27 Methods of inhibiting ovarian cancer

Publications (3)

Publication Number Publication Date
FI973521L FI973521L (fi) 1997-08-27
FI973521A0 FI973521A0 (fi) 1997-08-27
FI973521A7 true FI973521A7 (fi) 1997-08-27

Family

ID=23565226

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973521A FI973521A7 (fi) 1995-02-28 1996-02-27 Menetelmät munasarjasyövän inhiboimiseksi

Country Status (13)

Country Link
EP (1) EP0729755A2 (OSRAM)
JP (1) JPH11501033A (OSRAM)
KR (1) KR19980702553A (OSRAM)
CN (1) CN1176600A (OSRAM)
AU (1) AU5028696A (OSRAM)
CA (1) CA2214080A1 (OSRAM)
EA (1) EA199700200A1 (OSRAM)
FI (1) FI973521A7 (OSRAM)
HU (1) HUP9801327A3 (OSRAM)
IL (1) IL117277A0 (OSRAM)
NO (1) NO973963D0 (OSRAM)
WO (1) WO1996026727A1 (OSRAM)
ZA (1) ZA961564B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886025A (en) * 1997-03-06 1999-03-23 Baylor University Anti-mitotic agents which inhibit tubulin polymerization
AU781168B2 (en) * 2001-01-26 2005-05-12 Pfizer Products Inc. Method of treating certain cancers using an estrogen agonist/antagonist
FR2873692B1 (fr) * 2004-07-29 2006-12-01 Univ Claude Bernard Lyon COMPOSITIONS CONTENANT, EN ASSOCIATION AVEC UN AGENT ANTIMICROBIEN, UN COMPOSE THIOPHENIQUE OU BENZOTHIOPHENIQUE DE FORMULE(I)PRESENTANT UNE ACTIVITE INHIBITRICE DE POMPE NorA
CN103432141A (zh) * 2013-08-29 2013-12-11 南京大学 Chukrasone A在治疗卵巢癌药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
DE3586053D1 (de) * 1984-08-02 1992-06-17 Labrie Pharmazeutische zusammensetzung fuer die kombinationstherapie von hormonabhaengigem krebs.
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CA2118096A1 (en) * 1993-10-15 1995-04-16 Srinivasan Chandrasekhar Methods for treating resistant neoplasms
IL115582A0 (en) * 1994-10-14 1996-01-19 Lilly Co Eli Methods for treating resistant tumors

Also Published As

Publication number Publication date
NO973963L (no) 1997-08-28
KR19980702553A (ko) 1998-07-15
AU5028696A (en) 1996-09-18
HUP9801327A3 (en) 1999-10-28
CA2214080A1 (en) 1996-09-06
WO1996026727A1 (en) 1996-09-06
EP0729755A3 (OSRAM) 1996-09-11
HUP9801327A2 (hu) 1999-06-28
FI973521L (fi) 1997-08-27
JPH11501033A (ja) 1999-01-26
MX9706520A (es) 1997-11-29
NO973963D0 (no) 1997-08-28
EP0729755A2 (en) 1996-09-04
FI973521A0 (fi) 1997-08-27
CN1176600A (zh) 1998-03-18
EA199700200A1 (ru) 1998-02-26
IL117277A0 (en) 1996-06-18
ZA961564B (en) 1997-08-27

Similar Documents

Publication Publication Date Title
ID16345A (id) Senyawa-senyawa heterosiklik
DE69618660D1 (de) Schleifmittelträger
DE69627250D1 (de) Abschirmvorrichtung
PT858464E (pt) Inibidores de trombina
FI973529A7 (fi) Askomysiinejä
NO982566D0 (no) Forbindelser
FI960658L (fi) Uudet bis-naftalimidit syövän hoitamiseksi
NO974170D0 (no) Polyazacykloalkan-forbindelser
DE69607714D1 (de) Zusammengesetzte Rutsche
PT863916E (pt) Tripeptidos de polifluoroalquil triptofano inibidores de trombina
KR970004998A (ko) 시일드케이스
FI973521L (fi) Menetelmät munasarjasyövän inhiboimiseksi
KR970019328U (ko) 지중선로 보호판
FI970717L (fi) Menetelmät kohtusyövän inhiboimiseksi
DE69607764D1 (de) Induktives bauelement
FI102791B1 (fi) Induktiivinen komponentti
BR9610514A (pt) Inibidores cicloantihelmínticos
KR970000761U (ko) 앨범 내지
FI973499A7 (fi) Kasvaintenvastaisia bentsotiopyranoindatsoleja
KR970016581U (ko) 앨범용 대지
DE69611200D1 (de) Portal
FI952759A0 (fi) Rapumerta
NO950094D0 (no) Bæreanordning for langstrakte gjenstander
KR960030734U (ko) 앨범용 내지
ATA85395A (de) Abschirmung